TCL Archive Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve. April 13, 2007
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
TCL Archive Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015 November 26, 2014
TCL Archive The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data September 25, 1998
TCL Archive Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says. May 20, 2005
